Free Trial

FY2025 Earnings Forecast for AVR Issued By Cantor Fitzgerald

Anteris Technologies Global logo with Medical background

Anteris Technologies Global Corp (NASDAQ:AVR - Free Report) - Equities researchers at Cantor Fitzgerald issued their FY2025 earnings estimates for Anteris Technologies Global in a research report issued to clients and investors on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn expects that the company will post earnings per share of ($2.03) for the year. Cantor Fitzgerald currently has a "Overweight" rating and a $9.00 target price on the stock. The consensus estimate for Anteris Technologies Global's current full-year earnings is ($2.66) per share.

Several other research firms have also weighed in on AVR. Barclays assumed coverage on Anteris Technologies Global in a research report on Tuesday, January 7th. They set an "overweight" rating and a $22.00 price target on the stock. TD Cowen started coverage on Anteris Technologies Global in a report on Tuesday, January 7th. They set a "buy" rating and a $15.00 target price on the stock. Finally, Lake Street Capital assumed coverage on Anteris Technologies Global in a research note on Wednesday, January 8th. They set a "buy" rating and a $20.00 price target for the company.

Get Our Latest Research Report on Anteris Technologies Global

Anteris Technologies Global Stock Down 0.5 %

Shares of AVR traded down $0.03 during mid-day trading on Thursday, hitting $5.96. The company's stock had a trading volume of 97,240 shares, compared to its average volume of 182,417. Anteris Technologies Global has a fifty-two week low of $5.10 and a fifty-two week high of $6.10.

Anteris Technologies Global Company Profile

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Featured Articles

Should You Invest $1,000 in Anteris Technologies Global Right Now?

Before you consider Anteris Technologies Global, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anteris Technologies Global wasn't on the list.

While Anteris Technologies Global currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Nuclear energy is making a resurgence! Watch to find out which seven nuclear energy stocks could deliver long-term gains in the transition to cleaner energy.

Related Videos

Pelosi Bets Big on AI: Her Top 5 Stock Picks
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines